IRONWOOD PHARMACEUTICALS, INC.: 10-K filed 2018-02-22
What IRONWOOD PHARMACEUTICALS, INC. reported in its annual report filed 2018-02-22 (fiscal FY 2017): 38 published measures, 124 facts as tagged in accession 0001558370-18-000927.
This filing
- Form
- 10-K (annual report)
- Filed
- 2018-02-22
- Fiscal period
- fiscal FY 2017
- Accession
- 0001558370-18-000927 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IRONWOOD PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 605,674,000 | USD | |
| At 2016-12-31 | 709,821,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 9,848,000 | USD | |
| At 2016-12-31 | 66,716,000 | USD | |
| At 2015-12-31 | 95,125,000 | USD | |
| At 2014-12-31 | 88,552,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 125,736,000 | USD | |
| At 2016-12-31 | 54,004,000 | USD | |
| At 2015-12-31 | 261,287,000 | USD | |
| At 2014-12-31 | 74,297,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2017-12-31 | 12,085,000 | USD | 92 |
| 2017-01-01 to 2017-12-31 | -116,937,000 | USD | 365 |
| 2017-07-01 to 2017-09-30 | -32,297,000 | USD | 92 |
| 2017-04-01 to 2017-06-30 | -44,224,000 | USD | 91 |
| 2017-01-01 to 2017-03-31 | -52,501,000 | USD | 90 |
| 2016-10-01 to 2016-12-31 | -13,505,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | -81,708,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | -33,204,000 | USD | 92 |
| 2016-04-01 to 2016-06-30 | -21,702,000 | USD | 91 |
| 2016-01-01 to 2016-03-31 | -13,297,000 | USD | 91 |
| 2015-01-01 to 2015-12-31 | -142,669,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -99,563,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -25,433,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -106,927,000 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 4,211,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 4,206,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 4,049,000 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2017-12-31 | 94,208,000 | USD | 92 |
| 2017-01-01 to 2017-12-31 | 298,276,000 | USD | 365 |
| 2017-07-01 to 2017-09-30 | 86,825,000 | USD | 92 |
| 2017-04-01 to 2017-06-30 | 65,077,000 | USD | 91 |
| 2017-01-01 to 2017-03-31 | 52,166,000 | USD | 90 |
| 2016-10-01 to 2016-12-31 | 87,459,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | 273,957,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | 66,106,000 | USD | 92 |
| 2016-04-01 to 2016-06-30 | 54,350,000 | USD | 91 |
| 2016-01-01 to 2016-03-31 | 66,042,000 | USD | 91 |
| 2015-01-01 to 2015-12-31 | 149,555,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 19,835,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -4,176,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 303,070,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 151,460,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -177,674,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -9,153,000 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | -1,308,760,000 | USD | |
| At 2016-12-31 | -1,191,823,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 0 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 0 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 17,274,000 | USD | |
| At 2016-12-31 | 20,512,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 33,820,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 29,219,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 25,469,000 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -77,385,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -51,870,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -102,088,000 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 311,596,000 | USD | |
| At 2016-12-31 | 380,181,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 36,370,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 39,153,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 31,096,000 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 66,027,000 | USD | |
| At 2016-12-31 | 91,131,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 15,958,000 | USD | |
| At 2016-12-31 | 17,702,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 785,000 | USD | |
| At 2016-12-31 | 785,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 3,190,000 | USD | |
| At 2016-12-31 | 933,000 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 735,000 | USD | |
| At 2016-12-31 | 1,081,000 | USD | |
| At 2015-06-30 | 0 | USD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 19,097,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 1,868,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 12,000 | USD | 365 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 233,123,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 173,281,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 125,247,000 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 148,228,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 139,492,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 108,746,000 | USD | 365 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | -79,000 | USD | |
| At 2016-12-31 | -7,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 86,494,000 | USD | |
| At 2016-12-31 | 82,730,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 69,220,000 | USD | |
| At 2016-12-31 | 62,218,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 159,905,000 | USD | |
| At 2016-12-31 | 166,119,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 870,000 | USD | |
| At 2016-12-31 | 1,456,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 5,060,000 | USD | |
| At 2016-12-31 | 8,190,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-12-31 | 7,288,000 | USD | |
| At 2016-12-31 | 9,030,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -116,937,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -81,708,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -142,669,000 | USD | 365 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -117,009,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | -81,629,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -142,736,000 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 8,403,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 10,279,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 11,630,000 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 6,214,000 | USD | 365 |
| 2016-10-01 to 2016-12-31 | 3,300,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | 981,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | 3,200,000 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2017-12-31 | -10,680,000 | USD | 92 |
| 2017-01-01 to 2017-12-31 | -39,552,000 | USD | 365 |
| 2017-07-01 to 2017-09-30 | -12,863,000 | USD | 92 |
| 2017-04-01 to 2017-06-30 | -3,213,000 | USD | 91 |
| 2017-01-01 to 2017-03-31 | -12,796,000 | USD | 90 |
| 2016-10-01 to 2016-12-31 | -7,205,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | -29,838,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | -4,917,000 | USD | 92 |
| 2016-04-01 to 2016-06-30 | -6,387,000 | USD | 91 |
| 2016-01-01 to 2016-03-31 | -11,329,000 | USD | 91 |
| 2015-01-01 to 2015-12-31 | -40,581,000 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | 20,388,000 | USD | 365 |
| 2016-01-01 to 2016-12-31 | 24,473,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 22,742,000 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-12-31 | -346,000 | USD | 365 |
Inspect the source
- Entity
- IRONWOOD PHARMACEUTICALS, INC. / CIK 0001446847
- Captured
- 2026-09-20T09:04:45.983Z
- SEC response SHA-256
e907547bc46d38e028ac317d678e19520bc4135085f9133b1b1f54dc9a6016a4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001446847.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))